Literature DB >> 11153964

The epidemiology of onset and course of schizophrenia.

W an der Heiden1, H Häfner.   

Abstract

Traditionally the heterogeneity of schizophrenia was dealt with by subdividing the syndrome into different subtypes. However, due to lacking standards, the result was an immense variety of subtypes partly based on cross-sectional assessments, partly taken the whole course between onset, resp. first admission and outcome after many years into account. Some solutions were based on symptomatology only, others also relied on social characteristics as the ability to fulfil different roles in family and the world of employment. So it is not surprising that the number of subtypes ranges from two up to more than 70. As one possible solution Carpenter and Kirkpatrick (1988) suggest that attempts to subdivide the schizophrenic syndrome should concentrate on few significant parts of the course thought of to represent specific disease processes. Based on two epidemiological studies finding about the onset, middle course and late course of schizophrenia are presented. In three quarter of the cases the onset of the first psychotic episode in schizophrenia is preceded by a prodromal phase with a mean length of about five years. The earliest signs of the disorder are depressive and negative symptoms. Early depressive symptoms predict higher overall symptom scores in the first illness episode and lower scores for affective flattening in the medium-term course. There is no decrease in the number of patients with acute symptomatology over fifteen years after first hospital admission, rather there is a tendency of an increase. With respect to social abilities we found a significant increase of disability over time. But the change already takes place during the first five years. Approx. 60% of those falling ill with schizophrenia become chronic and approx. 25% will recover during the first five to six years.

Entities:  

Mesh:

Year:  2000        PMID: 11153964     DOI: 10.1007/s004060070004

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  39 in total

1.  Wellness within illness: happiness in schizophrenia.

Authors:  Barton W Palmer; Averria Sirkin Martin; Colin A Depp; Danielle K Glorioso; Dilip V Jeste
Journal:  Schizophr Res       Date:  2014-08-18       Impact factor: 4.939

2.  ["Scientific Evidence": or: "The methodical attraction of the lawnmower"].

Authors:  H Wollny
Journal:  Nervenarzt       Date:  2006-07       Impact factor: 1.214

Review 3.  [Early recognition and intervention for schizophrenia].

Authors:  N Mossaheb; G Wiesegger; G P Amminger; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2006-01       Impact factor: 1.214

4.  Dopamine D1 receptor activation improves PCP-induced performance disruption in the 5C-CPT by reducing inappropriate responding.

Authors:  S A Barnes; J W Young; S T Bate; J C Neill
Journal:  Behav Brain Res       Date:  2015-11-30       Impact factor: 3.332

5.  The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: an application of random effect regression models and propensity scores in an observational prospective trial.

Authors:  Reinhold Kilian; Matthias C Angermeyer
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

6.  Comorbid depressive symptoms in the developmental course of adolescent-onset psychosis.

Authors:  Marina Myles-Worsley; Starla Weaver; Francisca Blailes
Journal:  Early Interv Psychiatry       Date:  2007-08-15       Impact factor: 2.732

Review 7.  Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia.

Authors:  Y Chudasama; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2004-04-08       Impact factor: 4.530

8.  [The impact of the study design and the sampling procedure on the assessment of mental health services].

Authors:  R Kilian; C Roick; M C Angermeyer
Journal:  Nervenarzt       Date:  2003-06-26       Impact factor: 1.214

9.  Descriptive epidemiology of stigma against depression in a general population sample in Alberta.

Authors:  Trevor M Cook; Jianli Wang
Journal:  BMC Psychiatry       Date:  2010-04-19       Impact factor: 3.630

10.  Psychiatric disorders in clinical genetics II: Individualizing recurrence risks.

Authors:  Jehannine C Austin; Christina G S Palmer; Beth Rosen-Sheidley; Patricia McCarthy Veach; Elizabeth Gettig; Holly L Peay
Journal:  J Genet Couns       Date:  2007-12-11       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.